Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 951
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
for
Acute Monocytic Leukemia, Acute Myeloid Leukemia
Location: Portland OR, Miami FL
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06504459
Phase2, Recruiting
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
for
Atrial Fibrillation, Esophageal Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06067438
Phase2, Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Location: Portland OR, Stanford CA, Gilbert AZ, Westwood KS,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
IVIG for Infection Prevention After CAR-T-Cell Therapy
for
Hematologic Malignancies
Location: Portland OR, Seattle WA, Duarte CA, New York NY,
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT05952804
Phase2, Recruiting
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT06249191
Phase1, Phase2, Recruiting
Feasibility of FMISO in Brain Tumors
for
Malignant Brain Neoplasm
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT03649880
Phase2, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Portland OR, Seattle WA, Bakersfield CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase2, Recruiting
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
for
Acute Myeloid Leukemia,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06357182
Phase1, Recruiting
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT05705492
Phase2, Recruiting
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
for
Castration Resistant Prostate Cancer,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: Male
Age: 18+
Code: NCT05919329
Recruiting
Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07726602
Recruiting
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT04529044
Phase2, Recruiting
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer